Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals had revenue of $203.41K in the twelve months ending September 30, 2024, down -76.18% year-over-year. In the year 2023, Inovio Pharmaceuticals had annual revenue of $832.01K, down -91.89%.

• Revenue (ttm): $203.41K
• Revenue Growth: -76.18%
• P/S Ratio: 259.19
• Revenue / Employee: $1,667
• Employees: 122
• Market Cap: 75.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	832.01K	-9.43M	-91.89%
Dec 31, 2022	10.26M	8.49M	478.23%
Dec 31, 2021	1.77M	-5.64M	-76.05%
Dec 31, 2020	7.41M	3.30M	80.24%
Dec 31, 2019	4.11M	-26.37M	-86.51%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.